Leveljump Healthcare Corp. (FRA:75J)
Germany flag Germany · Delayed Price · Currency is EUR
0.0300
0.00 (0.00%)
At close: Dec 5, 2025

Leveljump Healthcare Statistics

Total Valuation

FRA:75J has a market cap or net worth of EUR 4.19 million. The enterprise value is 9.86 million.

Market Cap 4.19M
Enterprise Value 9.86M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date Nov 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 96.48M
Shares Outstanding n/a
Shares Change (YoY) +13.97%
Shares Change (QoQ) n/a
Owned by Insiders (%) 12.27%
Owned by Institutions (%) n/a
Float 64.01M

Valuation Ratios

The trailing PE ratio is 3.50.

PE Ratio 3.50
Forward PE n/a
PS Ratio 0.36
PB Ratio 1.08
P/TBV Ratio n/a
P/FCF Ratio 5.40
P/OCF Ratio 3.64
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.47, with an EV/FCF ratio of 12.71.

EV / Earnings 8.24
EV / Sales 0.84
EV / EBITDA 14.47
EV / EBIT 28.38
EV / FCF 12.71

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 1.46.

Current Ratio 0.56
Quick Ratio 0.23
Debt / Equity 1.46
Debt / EBITDA 8.43
Debt / FCF 7.30
Interest Coverage 0.53

Financial Efficiency

Return on equity (ROE) is 36.85% and return on invested capital (ROIC) is 2.44%.

Return on Equity (ROE) 36.85%
Return on Assets (ROA) 1.73%
Return on Invested Capital (ROIC) 2.44%
Return on Capital Employed (ROCE) 3.53%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.94
Inventory Turnover n/a

Taxes

Income Tax -1.34M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +25.00% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +25.00%
50-Day Moving Average 0.03
200-Day Moving Average 0.04
Relative Strength Index (RSI) 54.61
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:75J had revenue of EUR 11.57 million and earned 1.20 million in profits. Earnings per share was 0.01.

Revenue 11.57M
Gross Profit 3.04M
Operating Income 342,997
Pretax Income -140,482
Net Income 1.20M
EBITDA 580,135
EBIT 342,997
Earnings Per Share (EPS) 0.01
Full Income Statement

Balance Sheet

The company has 68,231 in cash and 5.67 million in debt, giving a net cash position of -5.60 million.

Cash & Cash Equivalents 68,231
Total Debt 5.67M
Net Cash -5.60M
Net Cash Per Share n/a
Equity (Book Value) 3.88M
Book Value Per Share 0.04
Working Capital -1.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.15 million and capital expenditures -374,709, giving a free cash flow of 776,136.

Operating Cash Flow 1.15M
Capital Expenditures -374,709
Free Cash Flow 776,136
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 26.27%, with operating and profit margins of 2.96% and 10.34%.

Gross Margin 26.27%
Operating Margin 2.96%
Pretax Margin -1.21%
Profit Margin 10.34%
EBITDA Margin 5.01%
EBIT Margin 2.96%
FCF Margin 6.71%

Dividends & Yields

FRA:75J does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.97%
Shareholder Yield -13.97%
Earnings Yield 28.58%
FCF Yield 18.53%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:75J has an Altman Z-Score of -0.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.19
Piotroski F-Score 4